Oil and gas have boomed in New Mexico. Its schools are contending with pollution's effects
COUNSELOR, N.M. — On a Tuesday in March, Billton Werito drove his son Amari toward his house in Counselor, New Mexico, navigating the bumpy dirt road that winds through a maze of natural gas pipelines , wellheads and water tanks. Amari should have been in school, but a bout of nausea and a dull headache kept him from class.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
E&E News
41 minutes ago
- E&E News
Mike Lee seeks to reinstate public lands sales in megabill
Senate Energy and Natural Resources Chair Mike Lee wants to revive public lands sales axed last month from the Republican tax, energy and security spending megabill. POLITICO's E&E News asked the Utah Republican Monday whether he intended to bring back public lands provisions that were cut from the House package. Lee, who was on his way to a procedural vote on a Defense department nominee, responded, 'I gotta go vote, but yes.' Last month, following a protracted intraparty battle, House leaders stripped the sale or transfer of nearly half a million acres in Nevada and Utah from the 'one, big, beautiful bill.' Advertisement The bill is now awaiting action in the Senate, where senators will retool it and return it to the House. POLITICO reported Monday that Senate committees, including Environment and Public Works, plan to begin releasing text as early as this week. Lee has long railed against federal ownership of lands in Western states. He frequently points out that roughly two-thirds of land in Utah is federally owned. On Monday, he did not elaborate on the details of what he plans to reintroduce. Lee's plans could add a major hurdle into the upper chamber's race to pass their version of the bill to unlock President Donald Trump's domestic agenda by July 4. Public lands sales are caustic to some members of the Senate like Sen. Steve Daines (R-Mont.), who has vowed to never vote for the sale of public lands. Senate Republicans can only afford to lose three votes on the legislation, which is being passed via budget reconciliation — a parliamentary measure that allows them to skirt the Senate's 60-vote filibuster. The return of public lands sales would also reignite anger from Democrats and public lands advocates, who have long worried about Lee's intentions. 'If Sen. Lee tries to reinsert public lands selloff provisions in the Senate bill, it shows just how out of touch he is with what Western Americans and Americans across the country want,' said Michael Carroll, public lands campaign director at the Wilderness Society, in an interview. 'Congress stripped that provision out of the budget bill and now it looks like this provision's going to have to get taken out of the Senate bill if and when Sen. Lee decides to move forward.' Public lands sales first entered the House reconciliation bill through a committee amendment from Reps. Mark Amodei (R-Nev.) and Celeste Maloy (R-Utah). Amodei and Maloy argued the amendment was carefully tailored to address housing needs, but opponents warned it would set a precedent that public lands can be sold any time Congress needs to raise revenues. The language was stripped by House leadership just hours before the vote after a push from Rep. Ryan Zinke (R-Mont.), Trump's first Interior secretary. He had threatened to vote against the whole bill unless the provision was removed.
CBS News
an hour ago
- CBS News
Chicago Fire reveal plans for new stadium in Chicago's South Loop
The Chicago Fire have announced plans to build a brand-new stadium. This will be a soccer-specific stadium, in the long-vacant plot of land in the South Sloop, known as "The 78." The team says it will be privately funded. It is estimated that it will house 22,000 fans. Construction will begin as soon as this fall and be finished in time for the 2028 Major League Soccer season.
Medscape
an hour ago
- Medscape
GLP-1 Less Frequent Dosing May Maintain Weight Loss
Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) administered at off-label reduced dosing maintained weight-loss benefits, with patients retaining the effects even with 2-4 weeks between doses. METHODOLOGY: GLP-1 RAs are transforming obesity treatment, but high costs and shortages limit patient access. Clinicians have suggested a less frequent dosing to maintain weight loss, but evidence supporting its effectiveness is lacking. Researchers used a combination of real-world case reports and mathematical modeling to examine the efficacy of a less frequent dosing of GLP-1 RAs for weight maintenance. They analyzed the data of two patients who used GLP-1 RAs at less frequent dosing schedules than recommended; patient 1 with obesity and prediabetes self-administered 7.5 mg tirzepatide every 10-14 days, whereas patient 2 with uncontrolled type 2 diabetes managed intermittent dosing of 15 mg tirzepatide due to supply shortages. A mathematical pharmacokinetic-pharmacodynamic model was used to simulate long-term changes in body weight of virtual patients administered semaglutide and tirzepatide at various dosing intervals. Simulations modeled semaglutide (2.4 mg) or tirzepatide (5 mg, 10 mg, or 15 mg) as a once-weekly dosing for 120 weeks, after which the 7-day dosing interval was increased to 10, 14, or 28 days or retained. TAKEAWAY: Patient 1 achieved an additional 13.7% body weight loss over 7 months and maintained it thereafter. Patient 2 lost 30% of her body weight and safely stopped insulin; even with intermittent dosing of tirzepatide, she retained a 22.8% body weight loss from baseline. Mathematical modeling predicted that switching from one dose per week to one dose every 2 weeks maintained 72% and 78% of the body weight loss achieved with 2.4 mg semaglutide and 15 mg tirzepatide, respectively. Even monthly dosing may have preserved half of the body weight loss achieved with weekly dosing, demonstrating that the reduction in efficacy was not proportional to the reduction in dosing frequency. IN PRACTICE: 'Future studies are needed to identify patient factors that predict a more favorable response to less frequent dosing of incretin mimetics and to examine the long-term clinical outcomes achieved through this approach compared with other off-ramping options (eg, switching to alternative AOMs [anti-obesity medications]),' the authors wrote. SOURCE: This study was led by Calvin C. Wu, Tono Health, Brooklyn, New York. It was published online in Obesity . LIMITATIONS: No limitations were provided for this study. DISCLOSURES: Two authors reported receiving funding from the National Science Foundation. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication. Credit Lead image: KKfotostock/Dreamstime Medscape Medical News © 2025 WebMD, LLC Cite this: Edited by Javed Choudhury. GLP-1 Less Frequent Dosing May Maintain Weight Loss - Medscape - June 03, 2025.
